Drug and Medication Analysis & Statistics in South Korea, October 2012 (p2)

You might be interested in: drug, vaccine, smoking cessation, more »

31-49 of 49 reports

Purchase Reports From Reputable Market Research Publishers

MarketVIEW: hepatitis A vaccines (travel)

MarketVIEW: hepatitis A vaccines (travel)

  • $ 5 995
  • Industry report
  • October 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Hepatitis A (HAV) produces a self-limiting liver disease which can produce a range of symptoms such as nausea, anorexia, fever, malaise or abdominal pain. Unlike Hepatitis B and C viruses it does not cause ...

  • Industries : Drug and Medication
  • Countries : United States, North America, World, South Korea, Europe, Australia, Brazil, Canada, United Kingdom, Sweden, Spain, Norway, Italy, France, Germany, Finland, Denmark
Yuhan Corporation (100) : Company Profile and SWOT Analysis

Yuhan Corporation (100) : Company Profile and SWOT Analysis

  • $ 125
  • Company report
  • July 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Yuhan Corporation (100) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company ...

  • Industries : Drug and Medication
  • Countries : South Korea
Orphan Drugs in Asia 2012: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2012

Orphan Drugs in Asia 2012: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2012

  • $ 1 500
  • Industry report
  • April 2012
  • by Pacific Bridge Medical

Historically, many drugs for rare diseases were developed to fulfill the needs of public health, rather than for drug companies' financial gain. Nevertheless, there is now a growing awareness of rare diseases ...

  • Industries : Drug and Medication
  • Countries : Asia, Japan, Taiwan, South Korea, China, World, Philippines, Singapore, Malaysia, United States, Vietnam, Thailand
Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market

Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market

  • $ 1 500
  • Industry report
  • April 2012
  • by Pacific Bridge Medical

Overview: Following the example of the US FDA's Orphan Drug Act established in 1983, some Asian countries have developed orphan drug legislations, such as Singapore's Orphan Drug Exemption to the Medicines ...

  • Industries : Drug and Medication
  • Countries : Asia, Japan, South Korea, Taiwan, China, World, Philippines, Singapore, United States, Malaysia
Sinil Pharma Ltd. (Symbol:012790) SWOT Analysis, Strategy, Revenues and Profits

Sinil Pharma Ltd. (Symbol:012790) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : South Korea
Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • February 2012
  • by ICD Research

Synopsis ICD Research's "Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Drug and Medication
  • Countries : Italy, Europe, Switzerland, South Africa, World, Vietnam, South Korea, India, China
MarketVIEW: universal pneumo vaccines

MarketVIEW: universal pneumo vaccines

  • $ 9 995
  • Industry report
  • January 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Vaccines to prevent serious infections caused by Streptococcus pneumoniae or "pneumo" currently form the largest component of the global vaccine market ($4 - 5bn/yr). Notable examples are Prevnar/Prevena ...

  • Industries : Drug and Medication
  • Countries : South Korea, Europe, World, Australia, Netherlands, United States, Canada, Spain, Portugal, Poland, Italy, Greece, France, Germany, Belgium, Japan, United Kingdom, Bangladesh, Brazil, Mexico, Gambia
Binex Co., Ltd. (Symbol:053030) SWOT Analysis, Strategy, Revenues and Profits

Binex Co., Ltd. (Symbol:053030) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • September 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : South Korea
Menarini Group: Company Profile and SWOT Analysis

Menarini Group: Company Profile and SWOT Analysis

  • $ 99
  • Company report
  • September 2011
  • by ICD Research

Synopsis ICD Research's "Menarini Group: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business ...

  • Industries : Drug and Medication
  • Countries : Italy, Europe, Switzerland, South Africa, World, Vietnam, South Korea, India, China
Drug and Medication in United States: Fever - Pipeline Review, Q3 2011

Drug and Medication in United States: Fever - Pipeline Review, Q3 2011

  • $ 500
  • Company report
  • July 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Fever, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...

  • Industries : Drug and Medication
  • Countries : United States, South Korea, World
Samsung Pharmaceutical Industry Corporation Limited. (Symbol:001360) SWOT Analysis, Strategy, Revenues and Profits

Samsung Pharmaceutical Industry Corporation Limited. (Symbol:001360) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : South Korea
Choongwae Pharma Corp (Symbol:001060) SWOT Analysis, Strategy, Revenues and Profits

Choongwae Pharma Corp (Symbol:001060) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : South Korea
Spices & Stimulants Market Overview in South Korea

Spices & Stimulants Market Overview in South Korea

  • $ 350
  • Industry report
  • April 2011
  • by MarketLine

The profile also contains descriptions of the key companies including key financial metrics and analysis of competitive pressures within the industry . Essential resource for top-line data and analysis ...

  • Industries : Drug and Medication
  • Countries : South Korea
Drug and Medication in United States: Fever - Pipeline Review, Q1 2011

Drug and Medication in United States: Fever - Pipeline Review, Q1 2011

  • $ 500
  • Company report
  • January 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Fever, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...

  • Industries : Drug and Medication, Pharmaceutical, Healthcare
  • Countries : United States, South Korea, World
Financial Health of Biotechnology and Drugs Companies in Rest of Asia

Financial Health of Biotechnology and Drugs Companies in Rest of Asia

  • $ 6 500
  • Industry report
  • December 2010
  • by Frost & Sullivan

The research services examines the financial performance of biotechnology companies across Rest of Asia across 2 broad parameters- Excellence in financial management and Excellence in risk management. ...

  • Industries : Drug and Medication
  • Countries : Asia, South Korea, Japan, World, Indonesia
UCB:  Pipeline - Products ? Performance - Potential

UCB: Pipeline - Products ? Performance - Potential

  • $ 1 043
  • Company report
  • January 2010
  • by Espicom Business Intelligence

UCB is a global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of CNS disorders, allergy/respiratory ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Europe, South Korea, Belgium, World, Switzerland, United States, Spain, Italy, Germany, Japan, India
Multi-client Study: Opportunities Assessment for the Hepatitis C Therapeutics Market in South Korea

Multi-client Study: Opportunities Assessment for the Hepatitis C Therapeutics Market in South Korea

  • $ 6 000
  • Industry report
  • December 2009
  • by Frost & Sullivan

This research service aims to provide an update on the epidemiology of Hepatitis C, including the prevalence and incidence, Market Engineering measurements, and government initiatives. It also covers patient ...

  • Industries : Therapy, Drug and Medication
  • Countries : South Korea
Systemic Fungal Infection Therapeutics Market - South Korea

Systemic Fungal Infection Therapeutics Market - South Korea

  • $ 6 000
  • Industry report
  • October 2009
  • by Frost & Sullivan

This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants ...

  • Industries : Therapy, Drug and Medication
  • Countries : South Korea
Rheumatoid Arthritis Therapeutics Market in South Korea

Rheumatoid Arthritis Therapeutics Market in South Korea

  • $ 6 000
  • Industry report
  • March 2009
  • by Frost & Sullivan

This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future ...

  • Industries : Therapy, Drug and Medication
  • Countries : South Korea
About 100 reports

Download Unlimited Documents from Trusted Public Sources

Yuhan - Company Report, July 2014

  • Pharmaceuticals & Biotechnology
  • July 2014
    36 pages
  • Drug  

  • South Korea  

    World  

View report >

Drug Industry

September 2013

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.